HLA-G and cervical carcinoma: Preoperation plasma levels of sHLA-G were significantly higher in cervical cancer patients than that of healthy controls (110.86 ± 172.33 U/mL vs. 36.93 ± 29.30 U/mL, P < 0.05) (Fig. 1).